Previous Close | 0.0210 |
Open | 0.0218 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0218 - 0.0218 |
52 Week Range | 0.0180 - 0.1080 |
Volume | |
Avg. Volume | 13,134 |
Market Cap | 484,618 |
Beta (5Y Monthly) | 0.87 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1000 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for WSNAF
CHICAGO and TORONTO, July 05, 2023 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE:WESA; OTCQB:WSNAF), today announced the successful closing of the sale by Wesana Health Inc. (“WHI”), a subsidiary of the Company, of WHI’s right and interest in the SANA-013 intellectual property and development related assets (the “Transaction”) pursuant to the terms of the asset purchase agreement with Lucy Scientific Discovery Inc. (NASDAQ:LSDI) (“Lucy”) dated March 20, 2023 (a
CHICAGO and TORONTO, June 09, 2023 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), today announced that all matters put forward at the Company’s annual general and special meeting (the “AGSM”) of shareholders (“Shareholders”) held on June 9, 2023 were duly approved by the requisite majority of votes cast at the AGSM. AGSM Results A total of approximately eighty percent (80%) of the votes entitled by the outstanding shares of the Company were